LATEST NR566 WEEK 4 MIDTERM EXAM QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS
RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains
• Pharmacokinetics & Pharmacodynamics
• Infectious Diseases & Antibiotics
• Endocrinology & Diabetes Management
• Cardiovascular & Hematologic Pharmacology
• Special Populations (Pregnancy, Pediatrics, Geriatrics)
Introduction
This comprehensive examination assesses the advanced pharmacologic
knowledge required for the NR566 Week 4 Midterm. It evaluates
pharmacokinetic principles, drug classification, therapeutic decision-
making, and management of complex conditions across the lifespan.
Questions emphasize clinical application, medication safety, and
evidence-based prescribing. The examination integrates multiple-choice
and scenario-based items covering infectious diseases, endocrinology,
and special populations. Successful completion demonstrates readiness
for advanced pharmacology practice in family care.
1. A drug with high first-pass metabolism is best administered via
which route to achieve systemic effect?
A. Oral
B. Sublingual
C. Intravenous
D. Rectal
Correct answer: C. Intravenous
, RATIONALE: IV administration completely bypasses first-pass
metabolism in the liver. Sublingual and rectal routes avoid it only
partially, but IV is most reliable for drugs with extensive first-pass
metabolism .
2. Which cytochrome P450 enzyme is most commonly involved in
clinically significant drug interactions?
A. CYP3A4
B. CYP1A2
C. CYP2C9
D. CYP2E1
Correct answer: A. CYP3A4
RATIONALE: CYP3A4 metabolizes over 50% of all drugs,
including statins, benzodiazepines, and calcium channel blockers,
making it the most frequent source of drug interactions .
3. A patient develops an exaggerated response to warfarin after
starting amiodarone. This interaction is due to:
A. Increased renal excretion
B. P-gp induction
C. CYP2C9 inhibition
D. Plasma protein binding displacement
Correct answer: C. CYP2C9 inhibition
RATIONALE: Amiodarone inhibits CYP2C9, the enzyme
responsible for warfarin metabolism. This inhibition increases INR and
bleeding risk .
,4. Which statement best describes a "prodrug"?
A. Active drug that requires no metabolism
B. Inactive compound converted to active metabolite in vivo
C. Drug that irreversibly binds to receptors
D. Drug excreted unchanged in urine
Correct answer: B. Inactive compound converted to active
metabolite in vivo
RATIONALE: Prodrugs like clopidogrel, enalapril, and codeine
require hepatic or tissue activation to become therapeutically active .
5. A drug with a narrow therapeutic index (NTI) requires:
A. Once-daily dosing only
B. Therapeutic drug monitoring
C. High protein binding
D. Renal adjustment always
Correct answer: B. Therapeutic drug monitoring
RATIONALE: NTI drugs (lithium, warfarin, phenytoin, digoxin)
have a small margin between efficacy and toxicity, necessitating routine
serum level monitoring .
6. A 75-year-old patient is prescribed a new medication that is
primarily renally excreted. Which adjustment is most appropriate?
A. Increase the dose
B. Decrease the dose or increase the dosing interval
C. No adjustment is needed
D. Administer the medication intravenously
Correct answer: B. Decrease the dose or increase the dosing interval
, RATIONALE: In older adults, renal function declines with age. For
medications primarily renally excreted, dose reduction or extended
dosing intervals are required to prevent accumulation and toxicity .
7. Which pharmacokinetic change occurs in pregnancy?
A. Increased gastric emptying time
B. Increased plasma volume leading to increased volume of distribution
C. Decreased hepatic metabolism
D. Decreased renal blood flow
Correct answer: B. Increased plasma volume leading to increased
volume of distribution
RATIONALE: Pregnancy causes increased plasma volume (up to
50%), increased cardiac output, and increased renal blood flow. The
increased volume of distribution may require higher doses of some
medications .
8. Which consideration is key when prescribing to a breastfeeding
mother?
A. Most drugs are contraindicated during breastfeeding
B. Drugs with long half-lives are preferred
C. Drugs with high protein binding and low oral bioavailability are less
likely to reach the infant
D. All medications are safe during breastfeeding
Correct answer: C. Drugs with high protein binding and low oral
bioavailability are less likely to reach the infant
RATIONALE: Highly protein-bound drugs remain in maternal
plasma and are less likely to pass into breast milk. Drugs with low oral
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS
RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains
• Pharmacokinetics & Pharmacodynamics
• Infectious Diseases & Antibiotics
• Endocrinology & Diabetes Management
• Cardiovascular & Hematologic Pharmacology
• Special Populations (Pregnancy, Pediatrics, Geriatrics)
Introduction
This comprehensive examination assesses the advanced pharmacologic
knowledge required for the NR566 Week 4 Midterm. It evaluates
pharmacokinetic principles, drug classification, therapeutic decision-
making, and management of complex conditions across the lifespan.
Questions emphasize clinical application, medication safety, and
evidence-based prescribing. The examination integrates multiple-choice
and scenario-based items covering infectious diseases, endocrinology,
and special populations. Successful completion demonstrates readiness
for advanced pharmacology practice in family care.
1. A drug with high first-pass metabolism is best administered via
which route to achieve systemic effect?
A. Oral
B. Sublingual
C. Intravenous
D. Rectal
Correct answer: C. Intravenous
, RATIONALE: IV administration completely bypasses first-pass
metabolism in the liver. Sublingual and rectal routes avoid it only
partially, but IV is most reliable for drugs with extensive first-pass
metabolism .
2. Which cytochrome P450 enzyme is most commonly involved in
clinically significant drug interactions?
A. CYP3A4
B. CYP1A2
C. CYP2C9
D. CYP2E1
Correct answer: A. CYP3A4
RATIONALE: CYP3A4 metabolizes over 50% of all drugs,
including statins, benzodiazepines, and calcium channel blockers,
making it the most frequent source of drug interactions .
3. A patient develops an exaggerated response to warfarin after
starting amiodarone. This interaction is due to:
A. Increased renal excretion
B. P-gp induction
C. CYP2C9 inhibition
D. Plasma protein binding displacement
Correct answer: C. CYP2C9 inhibition
RATIONALE: Amiodarone inhibits CYP2C9, the enzyme
responsible for warfarin metabolism. This inhibition increases INR and
bleeding risk .
,4. Which statement best describes a "prodrug"?
A. Active drug that requires no metabolism
B. Inactive compound converted to active metabolite in vivo
C. Drug that irreversibly binds to receptors
D. Drug excreted unchanged in urine
Correct answer: B. Inactive compound converted to active
metabolite in vivo
RATIONALE: Prodrugs like clopidogrel, enalapril, and codeine
require hepatic or tissue activation to become therapeutically active .
5. A drug with a narrow therapeutic index (NTI) requires:
A. Once-daily dosing only
B. Therapeutic drug monitoring
C. High protein binding
D. Renal adjustment always
Correct answer: B. Therapeutic drug monitoring
RATIONALE: NTI drugs (lithium, warfarin, phenytoin, digoxin)
have a small margin between efficacy and toxicity, necessitating routine
serum level monitoring .
6. A 75-year-old patient is prescribed a new medication that is
primarily renally excreted. Which adjustment is most appropriate?
A. Increase the dose
B. Decrease the dose or increase the dosing interval
C. No adjustment is needed
D. Administer the medication intravenously
Correct answer: B. Decrease the dose or increase the dosing interval
, RATIONALE: In older adults, renal function declines with age. For
medications primarily renally excreted, dose reduction or extended
dosing intervals are required to prevent accumulation and toxicity .
7. Which pharmacokinetic change occurs in pregnancy?
A. Increased gastric emptying time
B. Increased plasma volume leading to increased volume of distribution
C. Decreased hepatic metabolism
D. Decreased renal blood flow
Correct answer: B. Increased plasma volume leading to increased
volume of distribution
RATIONALE: Pregnancy causes increased plasma volume (up to
50%), increased cardiac output, and increased renal blood flow. The
increased volume of distribution may require higher doses of some
medications .
8. Which consideration is key when prescribing to a breastfeeding
mother?
A. Most drugs are contraindicated during breastfeeding
B. Drugs with long half-lives are preferred
C. Drugs with high protein binding and low oral bioavailability are less
likely to reach the infant
D. All medications are safe during breastfeeding
Correct answer: C. Drugs with high protein binding and low oral
bioavailability are less likely to reach the infant
RATIONALE: Highly protein-bound drugs remain in maternal
plasma and are less likely to pass into breast milk. Drugs with low oral
